Watch this webcast in which Director and Precision Medicine expert Marianne Fillion reveals how market research can unlock integral insights such as key customer trends, product adoption and patient leakage.

Tumor agnostic indications present specific challenges that must be addressed to achieve a successful launch and ensure wide access for all patients. To prepare for these complex product and indications launches, it is paramount for commercial teams to gain insights on tumor agnostic testing behaviors, including awareness, adoption, drivers and barriers.